Monsenso AS (OCSE:MONSO) Beneish M-Score: -5.07 (As of Jul. 13, 2026)

What is Monsenso AS Beneish M-Score?

Monsenso AS OCSE:MONSO +4.57% 29 Beneish M-Score is -5.07 as of Jul. 13, 2026. GuruFocus rates OCSE:MONSO with a GF Score™ of 29/100 and a GF Value™ of kr0.15 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 630 Healthcare Providers & Services companies, Monsenso AS ranks better than 96.19% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -5.07 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Monsenso AS's Beneish M-Score or its related term are showing as below:

OCSE:MONSO' s Beneish M-Score Range Over the Past 10 Years
Min: -5.07 Med: -3.61 Max: -0.6
Current: -5.07

During the past 9 years, the highest Beneish M-Score of Monsenso AS was -0.60. The lowest was -5.07. And the median was -3.61.

Monsenso AS Beneish M-Score Related Terms

Monsenso AS Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Monsenso AS's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Monsenso AS Beneish M-Score Chart

Monsenso AS Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Beneish M-Score

Get a 7-Day Free Trial

-3.61

-3.30

-3.89

-1.24

-5.07

Monsenso AS Semi-Annual Data
	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
Beneish M-Score	Get a 7-Day Free Trial											-3.89	0.00	-1.24	0.00	-5.07

OCSE:MONSO vs VEEV, BTSG, TEM: Beneish M-Score Comparison

For the Health Information Services subindustry, Monsenso AS's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Monsenso AS Beneish M-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Monsenso AS's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Monsenso AS's Beneish M-Score falls into.

Save Embed

29GF Score

Monsenso AS OCSE:MONSO

Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Monsenso AS Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Monsenso AS for today is based on a combination of the following eight different indices:

-4.84

0.92 * DSRI

0.528 * GMI

0.404 * AQI

0.892 * SGI

0.115 * DEPI

-4.84

0.92 * 0.9113

0.528 * 1.1033

0.404 * 1.114

0.892 * 0.7978

0.115 * 0.9991

0.172 * SGAI

4.679 * TATA

0.327 * LVGI

0.172 * 1.1247

4.679 * -0.438851

0.327 * 2.0741

-5.07

This Year (Dec25) TTM:

Last Year (Dec24) TTM:

Total Receivables was kr3.15 Mil.
Revenue was kr8.91 Mil.
Gross Profit was kr3.60 Mil.
Total Current Assets was kr3.82 Mil.
Total Assets was kr13.05 Mil.
Property, Plant and Equipment(Net PPE) was kr0.10 Mil.
Depreciation, Depletion and Amortization(DDA) was kr4.62 Mil.
Selling, General, & Admin. Expense(SGA) was kr1.80 Mil.
Total Current Liabilities was kr3.79 Mil.
Long-Term Debt & Capital Lease Obligation was kr1.65 Mil.
Net Income was kr-7.22 Mil.
Gross Profit was kr0.00 Mil.
Cash Flow from Operations was kr-1.49 Mil.

Total Receivables was kr4.34 Mil.
Revenue was kr11.17 Mil.
Gross Profit was kr4.98 Mil.
Total Current Assets was kr6.78 Mil.
Total Assets was kr18.49 Mil.
Property, Plant and Equipment(Net PPE) was kr0.10 Mil.
Depreciation, Depletion and Amortization(DDA) was kr4.43 Mil.
Selling, General, & Admin. Expense(SGA) was kr2.00 Mil.
Total Current Liabilities was kr3.71 Mil.
Long-Term Debt & Capital Lease Obligation was kr0.00 Mil.

1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI	=	(Receivables_t / Revenue_t)	/	(Receivables_t-1 / Revenue_t-1)
	=	(3.153 / 8.907)	/	(4.337 / 11.165)
	=	0.353991	/	0.388446
	=	0.9113

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI	=	GrossMargin_t-1	/	GrossMargin_t
	=	(GrossProfit_t-1 / Revenue_t-1)	/	(GrossProfit_t / Revenue_t)
	=	(4.983 / 11.165)	/	(3.603 / 8.907)
	=	0.446305	/	0.404513
	=	1.1033

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI	=	(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t)	/	(1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
	=	(1 - (3.822 + 0.099) / 13.05)	/	(1 - (6.78 + 0.099) / 18.49)
	=	0.69954	/	0.627961
	=	1.114

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI	=	Sales_t	/	Sales_t-1
	=	Revenue_t	/	Revenue_t-1
	=	8.907	/	11.165
	=	0.7978

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI	=	(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1))	/	(Depreciation_t / (Depreciaton_t + PPE_t))
	=	(4.428 / (4.428 + 0.099))	/	(4.621 / (4.621 + 0.099))
	=	0.978131	/	0.979025
	=	0.9991

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI	=	(SGA_t / Sales_t)	/	(SGA_t-1 /Sales_t-1)
	=	(1.798 / 8.907)	/	(2.004 / 11.165)
	=	0.201864	/	0.179489
	=	1.1247

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI	=	((LTD_t + CurrentLiabilities_t) / TotalAssets_t)	/	((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
	=	((1.648 + 3.786) / 13.05)	/	((0 + 3.712) / 18.49)
	=	0.416398	/	0.200757
	=	2.0741

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA	=	(IncomefromContinuingOperations_t	-	CashFlowsfromOperations_t)	/	TotalAssets_t
	=	(NetIncome_t - NonOperatingIncome_t	-	CashFlowsfromOperations_t)	/	TotalAssets_t
	=	(-7.217 - 0	-	-1.49)	/	13.05
	=	-0.438851

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Monsenso AS has a M-score of -5.07 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →

What does a Beneish M-Score of -5.07 mean?

Monsenso AS (OCSE:MONSO) has a Beneish M-Score of -5.07 as of Jul. 13, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Monsenso AS and its competitors. According to the industry distribution chart, Monsenso AS ranks #24 out of 630 companies in the Healthcare Providers & Services industry, placing it in the top 3.8%.

Is Monsenso AS's Beneish M-Score too high?

Monsenso AS's current Beneish M-Score is -5.07. Based on the distribution chart, Monsenso AS ranks #24 out of 630 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Monsenso AS has a GF Score™ of 29/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Monsenso AS's Beneish M-Score compare to VEEV and BTSG?

According to the Healthcare Providers & Services industry distribution chart, Monsenso AS ranks #24 out of 630 companies for Beneish M-Score. This places Monsenso AS in the top 4% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Beneish M-Score for a Healthcare Providers & Services company?

A good Beneish M-Score depends on the Healthcare Providers & Services industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Beneish M-Score mean?

A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Monsenso AS and its competitors. Monsenso AS's current Beneish M-Score is -5.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Monsenso AS stock overvalued right now?

Based on GuruFocus' analysis, Monsenso AS (OCSE:MONSO) is currently considered Significantly Overvalued. The stock's GF Value™ is kr0.15, compared to a current price of kr0.37 — trading 144% above its estimated fair value. The current Beneish M-Score is -5.07. Monsenso AS's overall GF Score™ is 29/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Beneish M-Score calculated?

Beneish M-Score is calculated from a company's financial statements. For Monsenso AS (OCSE:MONSO), the current Beneish M-Score is -5.07 as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Monsenso AS (OCSE:MONSO) Overvalued in 2026?

Based on GuruFocus' analysis, Monsenso AS stock appears to be overvalued. The current stock price of kr0.37 is trading 144% above its estimated GF Value™ of kr0.15. GuruFocus considers Monsenso AS to be Significantly Overvalued.

Key valuation signals for OCSE:MONSO:

Beneish M-Score: -5.07
GF Value™: kr0.15 vs. price of kr0.37 (144% above fair value)
GF Score™: 29/100 with 8 warning signs

No single metric tells the full story. See the OCSE:MONSO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Monsenso AS Business Description

Industry Healthcare Healthcare Providers & Services

Comparable Companies VEEV ASX:PME BTSG TEM HQY TSE:2413 HNGE TXG DOCS WAY HKSE:02228 PRVA HTFL NSE:IKS SZSE:300253 NSE:SAGILITY OMCL HKSE:01833 TDOC SGX:ULG

Address Rosenorns Alle 31, 2, Frederiksberg, DNK, DK-1970

Website https://www.monsenso.com

Monsenso AS is a mobile mental health company. It technology company offering a digital health solution used for decentralized trials, remote patient monitoring, and treatment support. The company's mission is to contribute to improved health for more people at lower costs by supporting treatment digitally and leveraging patient-reported outcomes data, and the solution helps optimise the treatment and gives a detailed overview of an individual's health through the collection of outcome, adherence, and behavioral data.

29GF Score

Get the complete analysis for OCSE:MONSO

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.37

Price

kr0.15

GF Value

View OCSE:MONSO Analysis

See Beneish M-Score data for all stocks →